Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Reata Pharmaceuticals Two Stories: Updated News of its Clinical Programs and Finances

August 11, 2021 0

Reata Pharmaceuticals Two Stories Omaveloxolone in Patients with Friedreich’s Ataxia Several communications between Reata Pharmaceuticals (RETA) …

Agenus Inc Corporate Update and Financial Results for Q2 2021. See Also: Why Intellia Was Down Today

August 9, 2021 0

Agenus Inc News and Q2 Results for 201 Agenus (AGEN) announced results with better than usual …

A Reevaluation of Prohost Biotech’s Picked Firms

August 9, 2021 0

Prohost Letter #446 A Reevaluation of Prohost Biotech’s Picked Firms We have already pinpointed some of …

The U.S. FDA Accepts Exelixis sNDA of CABOMETYX® for Priority Review

August 6, 2021 0

Exelixis sNDA Accepted by the US FDA for CABOMETYX® The U.S. Food and Drug Administration (FDA) …

Novartis Announces Lift of Partial Clinical Trial Hold. See Also: Plans to Initiate a New SMA Study

August 4, 2021 0

Novartis Partial Clinical Trial Hold for OAV-101 IT for SMA Lifted Novartis (NVS) announced that the …

Sanofi to Acquire Translate Bio, Advancing mRNA Technology. See Also: Cassava Science Q2 Financial Results

August 3, 2021 0

Sanofi Will Acquire Translate Bio Sanofi (SNY) will acquire all the outstanding shares of Translate Bio (

AstraZeneca: Big Step Towards Improving the Lives of SLE Patients and More on Cassava Sciences

August 2, 2021 0

Cassava Sciences There is no doubt in our minds that Cassava Sciences’ (SAVA) product simufilam will …

Cassava Sciences Good News and an Unwarranted Sell-Off. A New Drug Approval for Bristol-Myers Squibb and ImmunoGen Quarterly Results

July 30, 2021 0

Cassava Sciences Inc Following Cassava Sciences Inc successful and promising presentations, all the titles of the …

Cassava Sciences Inc: Today’s Press Releases

July 29, 2021 0

Cassava Sciences Inc Press Release Related to Positive Biomarker Data Cassava Sciences Inc (SAVA) announced today, …

GlaxoSmithKline and Vir Biotechnology Announce Joint Procurement Agreement with the EC for COVID-19 Treatment

July 28, 2021 0

GlaxoSmithKline and Vir Biotechnology Signed a Joint Procurement Agreement with the EC GlaxoSmithKline (GSK) and Vir Biotechnology …

Cassava Sciences Announces Positive Data with SavaDx from a Randomized Controlled Phase 2b Study of Simufilam

July 26, 2021 0

Cassava Sciences: Positive Clinical Data with SavaDX Cassava Sciences (SAVA) today announced positive clinical data with SavaDx, …

bluebird bio Receives Approval for its Gene Therapy SKYSONA™ for Young People with Early CALD Without a Matched Sibling Donor

July 22, 2021 0

bluebird bio Receives EC Approval for bluebird bio (BLUE) announced that the European Commission (EC) has granted marketing authorization …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Reata Pharmaceuticals Two Stories: Updated News of its Clinical Programs and Finances

Agenus Inc Corporate Update and Financial Results for Q2 2021. See Also: Why Intellia Was Down Today

A Reevaluation of Prohost Biotech’s Picked Firms

The U.S. FDA Accepts Exelixis sNDA of CABOMETYX® for Priority Review

Novartis Announces Lift of Partial Clinical Trial Hold. See Also: Plans to Initiate a New SMA Study

Sanofi to Acquire Translate Bio, Advancing mRNA Technology. See Also: Cassava Science Q2 Financial Results

AstraZeneca: Big Step Towards Improving the Lives of SLE Patients and More on Cassava Sciences

Cassava Sciences Good News and an Unwarranted Sell-Off. A New Drug Approval for Bristol-Myers Squibb and ImmunoGen Quarterly Results

Cassava Sciences Inc: Today’s Press Releases

GlaxoSmithKline and Vir Biotechnology Announce Joint Procurement Agreement with the EC for COVID-19 Treatment

Cassava Sciences Announces Positive Data with SavaDx from a Randomized Controlled Phase 2b Study of Simufilam

bluebird bio Receives Approval for its Gene Therapy SKYSONA™ for Young People with Early CALD Without a Matched Sibling Donor

Cassava Sciences Stock Soared. See Also: The Resurrection of Sunesis Pharmaceuticals

Immunome Inc Stock Rallied After Announcing it Neutralized the SARS-CoV-2 Delta Variant.

Why Cytokinetics’ Stock Price Soared in a Bad Market Day

Important Steps Forward Taken by Vir Biotechnology and Separately by Compugen

Encouraging News from Hoth Therapeutics and Kintor Pharmaceutical Ltd About Treating Acne and Alopecia

Halozyme Announced Janssen Received U.S. FDA Approval of DARZALEX FASPRO®. See Also: IVERIC bio News

Companies Behind the Biotechnology Revolution

Why Celldex Therapeutics Stock is Soaring